NAION risk with semaglutide: what we know so far.
作者信息
Hsu Alan Y, Wang Yu-Hsun, Lin Chun-Ju, Hsia Ning-Yi, Shao Yi-Ching, Chiang Chun-Chi, Chen Huan-Sheng, Tsai Yi-Yu, Wei James Cheng-Chung
机构信息
Department of Ophthalmology, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.
出版信息
Eye (Lond). 2025 Jun;39(9):1655-1656. doi: 10.1038/s41433-025-03833-y. Epub 2025 May 7.
Abstract
摘要
相似文献
1
NAION risk with semaglutide: what we know so far.司美格鲁肽与非动脉炎性前部缺血性视神经病变的风险：我们目前所了解的情况。
Eye (Lond). 2025 Jun;39(9):1655-1656. doi: 10.1038/s41433-025-03833-y. Epub 2025 May 7.
2
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.司美格鲁肽处方治疗患者发生非动脉炎性前部缺血性视神经病变的风险。
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
3
The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy.司美格鲁肽和胰高血糖素样肽-1受体激动剂对非动脉性前部缺血性视神经病变风险的影响。
Am J Ophthalmol. 2025 Jun;274:24-31. doi: 10.1016/j.ajo.2025.02.025. Epub 2025 Feb 25.
4
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes.司美格鲁肽与糖尿病患者非动脉炎性前部缺血性视神经病变风险
JAMA Ophthalmol. 2025 May 1;143(5):400-407. doi: 10.1001/jamaophthalmol.2025.0349.
5
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.司美格鲁肽与非动脉炎性前部缺血性视神经病变
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
6
Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.司美格鲁肽与非动脉炎性前部缺血性视神经病变：对已报道关联的综述与解读
Acta Ophthalmol. 2025 Mar 8. doi: 10.1111/aos.17473.
7
Association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Study.司美格鲁肽与非动脉炎性前部缺血性视神经病变之间的关联：一项基于多国人群的研究。
Ophthalmology. 2025 Apr;132(4):381-388. doi: 10.1016/j.ophtha.2024.10.030. Epub 2024 Nov 2.
8
Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes.在丹麦一个由424152名2型糖尿病患者组成的队列中，每周一次的司美格鲁肽使非动脉炎性前部缺血性视神经病变的五年风险增加了一倍。
Int J Retina Vitreous. 2024 Dec 18;10(1):97. doi: 10.1186/s40942-024-00620-x.
9
"I Don't Understand Their Sense of Belonging": Exploring How Nonbinary Autistic Adults Experience Gender.“我不理解他们的归属感”：探索非二元性别的自闭症成年人如何体验性别。
Autism Adulthood. 2024 Dec 2;6(4):462-473. doi: 10.1089/aut.2023.0071. eCollection 2024 Dec.
10
"In a State of Flow": A Qualitative Examination of Autistic Adults' Phenomenological Experiences of Task Immersion.“心流状态”：对自闭症成年人任务沉浸现象学体验的质性研究
Autism Adulthood. 2024 Sep 16;6(3):362-373. doi: 10.1089/aut.2023.0032. eCollection 2024 Sep.
本文引用的文献
1
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy Risk Among Patients With Diabetes.司美格鲁肽与糖尿病患者非动脉炎性前部缺血性视神经病变风险
JAMA Ophthalmol. 2025 May 1;143(5):400-407. doi: 10.1001/jamaophthalmol.2025.0349.
2
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy.司美格鲁肽与非动脉炎性前部缺血性视神经病变
JAMA Ophthalmol. 2025 Apr 1;143(4):304-314. doi: 10.1001/jamaophthalmol.2024.6555.
3
Association between Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: A Multinational Population-Based Study.司美格鲁肽与非动脉炎性前部缺血性视神经病变之间的关联：一项基于多国人群的研究。
Ophthalmology. 2025 Apr;132(4):381-388. doi: 10.1016/j.ophtha.2024.10.030. Epub 2024 Nov 2.
4
Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.司美格鲁肽处方治疗患者发生非动脉炎性前部缺血性视神经病变的风险。
JAMA Ophthalmol. 2024 Aug 1;142(8):732-739. doi: 10.1001/jamaophthalmol.2024.2296.
5
Nonarteritic anterior ischemic optic neuropathy: cause, effect, and management.非动脉炎性前部缺血性视神经病变：病因、影响及治疗
Eye Brain. 2017 Sep 27;9:23-28. doi: 10.2147/EB.S125311. eCollection 2017.
Zotero 插件